Stock comparison
LifeStance Health Group, Inc. is 2.0x more valuable than GeneDx Holdings Corp. by market capitalization ($4.19 B vs $2.10 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LFST is larger
LifeStance Health Group, Inc. is 2.0x more valuable than GeneDx Holdings Corp. by market capitalization ($4.19 B vs $2.10 B).
Market value leader
LFST
LifeStance Health Group, Inc. is 2.0x more valuable than GeneDx Holdings Corp. by market capitalization ($4.19 B vs $2.10 B).
Revenue leader
LFST
WGS: $427.54M vs LFST: $1.42B.
Profit leader
LFST
WGS: -$21.00M vs LFST: $9.66M.
Margin leader
LFST
WGS: -4.9% vs LFST: 0.7% net margin.
| Metric | WGS | LFST |
|---|---|---|
| Market cap | $2.10 B | $4.19 B |
| US-listed rank | #2102 | #1559 |
| Revenue (latest FY) | $427.54M | $1.42B |
| Net income (latest FY) | -$21.00M | $9.66M |
| Net margin | -4.9% | 0.7% |
| P/E (trailing FY) | - | 433.5x |
| SEC filings | 748 | 452 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
LifeStance Health Group, Inc. is 2.0x more valuable than GeneDx Holdings Corp. by market capitalization ($4.19 B vs $2.10 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while LifeStance Health Group, Inc. reported $1.42B.
Full pages: GeneDx Holdings Corp. and LifeStance Health Group, Inc., or browse the full rankings.